MT-RNR2 and early-onset autosomal dominant Alzheimer disease: The peptide Humanin was first described in 2001 (Hashimoto et al., 2001) when it was observed during a study on Alzheimer's disease (AD) that the death of cells was prevented by the presence of the peptide.